Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-7-(beta-d-glucopyranosyloxy)-5-hydroxy-
2. Cinaroside
3. Galuteolin
4. Luteolin-7-beta-d-glucoside
5. Luteolin-7-glucoside
6. Luteolin-7-o-beta-d-glucopyranoside
7. Luteolin-7-o-glucoside
8. Luteolin-7-o-monoglucoside
9. Luteoloside
10. Nephrocizin
11. Nephrocizine
1. Luteoloside
2. 5373-11-5
3. Luteolin 7-glucoside
4. Luteolin-7-o-glucoside
5. Cinaroside
6. Glucoluteolin
7. Luteolin 7-o-glucoside
8. 7-glucoluteolin
9. 7-glucosylluteolin
10. Luteolin-7-glucoside
11. Luteolin 7-monoglucoside
12. Luteolin 7-o-beta-d-glucoside
13. Luteolin 7-o-glucopyranoside
14. Flavopurposide
15. Daphneflavonoloside
16. 7-o-beta-d-glucosyl-5,7,3',4'-tetrahydroxyflavone
17. Mls002473222
18. 98j6xds46i
19. Chembl233929
20. 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
21. 26811-41-6
22. Luteolin 7-.beta.-d-glucoside
23. Chebi:27994
24. Smr000232358
25. 2-(3,4-dihydroxyphenyl)-7-(beta-d-glucopyranosyloxy)-5-hydroxy-4h-1-benzopyran-4-one
26. Luteolin-7-o-d-glucopyranoside
27. Nephrocizin
28. Luteolin Glucoside
29. 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4h-chromen-7-yl Beta-d-glucopyranoside
30. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-7-(.beta.-d-glucopyranosyloxy)-5-hydroxy-
31. 4h-1-benzopyran-4-one,2-(3,4-dihydroxyphenyl)-7-(b-d-glucopyranosyloxy)-5-hydroxy-
32. 7-(beta-d-glucopyranosyloxy)-5-hydroxy-2-(3,4-dihydroxyphenyl)-4h-chromen-4-one
33. 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
34. 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4h-chromen-4-one
35. Luteolin, Glucoside
36. Nephrocizine
37. Luteolin Monoglucoside
38. Sr-01000867987
39. Nsc-724451
40. 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
41. Einecs 226-365-8
42. Mfcd06799436
43. Luteolin 7-beta-glucoside
44. Luteolin 7-o-d-glucoside
45. Flavon, 3',4',5,7-tetrahydroxy-, Glucoside
46. Luteolin 7-o--d-glucoside
47. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-7-(beta-d-glucopyranosyloxy)-5-hydroxy-
48. Luteolin-7-o-beta-glucoside
49. Unii-98j6xds46i
50. Luteolin 7-o-b-d-glucoside
51. Luteolin-7-d-glucopyranoside
52. Schembl149118
53. Luteolin 7-b-d-glucopyranoside
54. Megxp0_000619
55. Luteolin-7-o-glucoside ,(s)
56. Regid_for_cid_657946
57. Cid_5280637
58. Dtxsid50949617
59. Regid_for_cid_5280637
60. Hms2224o21
61. Luteolin 7-glucoside [mi]
62. Flavone, 3',4',5,7-tetrahydroxy-, Mono-beta-d-glucopyranoside
63. Hy-n0540
64. Zinc4096258
65. 7-.beta.-d-glucosylluteolin
66. Bdbm50241242
67. Luteolin 7-.beta.-d-glucopyranoside
68. S9018
69. Akos015903261
70. Ac-6054
71. Ccg-269211
72. Cs-5712
73. Luteolin 7-o-.beta.-glucoside
74. Nsc 724451
75. Luteolin 7-o-.beta.-d-glucoside
76. Luteolin 7-o-glucoside [usp-rs]
77. Ncgc00163589-01
78. Ncgc00163589-02
79. As-73889
80. Luteolin 7-glucoside, Analytical Standard
81. Luteolin 5-o-.beta.-glucopyranoside
82. Luteolin 7-o-.beta.-glucopyranoside
83. N1724
84. N2724
85. Luteolin 7-o-.beta.-d-glucopyranoside
86. Luteolin, 7-.beta.-d-glucopyranoside
87. Luteolin-7-o-4c1-.beta.-d-glucoside
88. C03951
89. 373l115
90. Luteolin 7-o-beta-d-glucoside, >=98.0% (hplc)
91. Luteolin-7-o-glucoside 1000 Microg/ml In Ethanol
92. Q2317288
93. Sr-01000867987-2
94. Sr-01000867987-3
95. 7-(.beta.-d-glucosyloxy)-3',4',5-trihydroxyflavone
96. Luteolin 7-glucoside, Primary Pharmaceutical Reference Standard
97. 3',4',5,7-tetrahydroxyflavone 7-.beta.-d-glucopyranoside
98. 3',4',5-trihydroxyflavone 7-o-.beta.-d-glucopyranoside
99. 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4h-chromen-7-yl Hexopyranoside #
100. Luteolin 7-o-glucoside, United States Pharmacopeia (usp) Reference Standard
101. 4h-1-benzopyran-4-one,2-(3,4-dihydroxyphenyl)-7-(
102. A-d-glucopyranosyloxy)-5-hydroxy-
103. 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one
104. 2-(3,4-dihydroxyphenyl)-7-(.beta.-d-glucopyranosyloxy)-5-hydroxy-4h-1-benzopyran-4-one
105. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, Mono-beta-d-glucopyranoside
| Molecular Weight | 448.4 g/mol |
|---|---|
| Molecular Formula | C21H20O11 |
| XLogP3 | 0.5 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 4 |
| Exact Mass | 448.10056145 g/mol |
| Monoisotopic Mass | 448.10056145 g/mol |
| Topological Polar Surface Area | 186 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 714 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
34
PharmaCompass offers a list of Cynaroside API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cynaroside manufacturer or Cynaroside supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cynaroside manufacturer or Cynaroside supplier.
PharmaCompass also assists you with knowing the Cynaroside API Price utilized in the formulation of products. Cynaroside API Price is not always fixed or binding as the Cynaroside Price is obtained through a variety of data sources. The Cynaroside Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cynaroside manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cynaroside, including repackagers and relabelers. The FDA regulates Cynaroside manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cynaroside API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cynaroside supplier is an individual or a company that provides Cynaroside active pharmaceutical ingredient (API) or Cynaroside finished formulations upon request. The Cynaroside suppliers may include Cynaroside API manufacturers, exporters, distributors and traders.
Cynaroside Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cynaroside GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cynaroside GMP manufacturer or Cynaroside GMP API supplier for your needs.
A Cynaroside CoA (Certificate of Analysis) is a formal document that attests to Cynaroside's compliance with Cynaroside specifications and serves as a tool for batch-level quality control.
Cynaroside CoA mostly includes findings from lab analyses of a specific batch. For each Cynaroside CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cynaroside may be tested according to a variety of international standards, such as European Pharmacopoeia (Cynaroside EP), Cynaroside JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cynaroside USP).
